Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cosmos Health (COSM) Operating Income (2016 - 2025)

Cosmos Health's Operating Income history spans 13 years, with the latest figure at -$11.4 million for Q4 2025.

  • Quarterly results put Operating Income at -$11.4 million for Q4 2025, down 458.74% from a year ago — trailing twelve months through Dec 2025 was -$16.7 million (down 391.51% YoY), and the annual figure for FY2025 was -$16.7 million, down 391.51%.
  • Operating Income for Q4 2025 was -$11.4 million at Cosmos Health, down from -$1.8 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $3.2 million in Q4 2024 to a low of -$13.6 million in Q4 2023.
  • The 5-year median for Operating Income is -$1.8 million (2024), against an average of -$2.7 million.
  • The sharpest move saw Operating Income crashed 3364.71% in 2023, then surged 123.4% in 2024.
  • Year by year, Operating Income stood at -$511284.0 in 2021, then plummeted by 1327.35% to -$7.3 million in 2022, then plummeted by 86.17% to -$13.6 million in 2023, then surged by 123.4% to $3.2 million in 2024, then crashed by 458.74% to -$11.4 million in 2025.
  • According to Business Quant data, Operating Income over the past three periods came in at -$11.4 million, -$1.8 million, and -$2.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.